Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
Both candidates for the US presidency are advocating policies that would create a new pricing environment for pharma companies – but we’ve been here before. With regard to the Affordable Care Act, however, the election could prove a real turning point.
The pharma industry creates significant amounts of data – so why is most of it hoarded and never made accessible?
The COVID-19 pandemic has caused worldwide disruption, but how has the it affected African pharma?
QC must evolve to meet progress in biopharmaceutical manufacturing.
What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?
Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?
The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?
A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.
Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.
Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.
Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.
Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.
Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.
Bethesda, MD, USA
Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD, October 26-28, 2020. This...
Join 2000+ cell and gene commercial leaders for this free conference and get treatments to patients faster.
The 2020 #ISPE Annual Meeting & Expo is an immersive interactive event for the global pharma community. Join your...
Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD, October 26-28, 2020. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain; making it easy to network with peers, and leading to new, beneficial connections.
The 2020 #ISPE Annual Meeting & Expo is an immersive interactive event for the global pharma community. Join your colleagues worldwide as we come together for 60+ hours of thought-provoking sessions led by leading experts from ANSM, FDA, Kite Pharma, GSK, Health Canada, MHRA, WHO, Vetter Pharma, and more!
You might be interested in our Sister Publications:
by Thermo Fisher Scientific
Cell therapy logistics is challenged by complex processes, inefficiency, and lack of flexibility to accommodate manufacturing, clinic, and patient needs
by Erbi Biosystems
Upstream process intensification efforts are becoming mainstream in every biopharma R&D lab and clinical program.
With this webinar we pretend to look at the different sorts of impurities that may occur in pharmaceutical products and discuss current regulations, requirements and control strategies to be followed in order to comply with the current demands.
Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.
Trials of a Medicine Maker
Can we trust the integrity of clinical trials?
Are current dosage forms really as easy and convenient for patients as pharma manufacturers say they are?
Robert W. Lee
Why drug developers should take a fresh look at long-acting dosage forms.
When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.
Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.
Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.